Tilray Brands, Inc. (TLRY)

CA — Healthcare Sector
Peers: BGM  ANIP  QDEL  PAHC  BHVN  HROW  CLDX  VRDN  ATRC  SSII 

Automate Your Wheel Strategy on TLRY

With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TLRY
  • Rev/Share 1.0196
  • Book/Share 1.4342
  • PB 0.9772
  • Debt/Equity 0.1501
  • CurrentRatio 2.6198
  • ROIC -1.6144

 

  • MktCap 1586733164.0
  • FreeCF/Share -0.1129
  • PFCF -13.2555
  • PE -0.5008
  • Debt/Assets 0.1111
  • DivYield 0
  • ROE -0.9686

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock?
TLRY
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Tilray Brands (TLRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Read More
image for news Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock?
Should You Buy TLRY Stock After Encouraging Q1 Results?
TLRY
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive

Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.

Read More
image for news Should You Buy TLRY Stock After Encouraging Q1 Results?
Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season
APLD, LEVI, PEP, TLRY
Published: October 10, 2025 by: Proactive Investors
Sentiment: Neutral

This week marked the start of earnings season with several major companies reporting results, including Delta Air Lines and PepsiCo, while the big banks like JPMorgan Chase, Citigroup, and Wells Fargo are set to report next week. Investors are closely watching these early reports for cues on the broader economic landscape amid ongoing uncertainties.

Read More
image for news Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season
Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript
TLRY
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Neutral

Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - President, CEO & Chairman Carl Merton - CFO & Principal Accounting Officer Lloyd Brathwaite - Chief Information Officer Blair MacNeil - President of Tilray Canada Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Xin Ma - TD Cowen, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Presentation Operator Thank you for joining today's conference call to discuss …

Read More
image for news Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript
Tilray: Another Blah Quarter
TLRY
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Positive

Tilray Brands surged after FQ1 results, but the business shows minimal growth and is no longer focused on key cannabis sales. TLRY's revenue growth was driven mainly by acquisitions and currency gains, not organic expansion, with weak margins and declining beverage sales. The stock's rally is based on U.S. cannabis rescheduling hopes, yet TLRY lacks exposure to the U.S. cannabis market and trades at a high valuation at 36x adj. EBITDA forecasts.

Read More
image for news Tilray: Another Blah Quarter
Q3 Earnings Season Begins On Positive Note
DAL, PEP, TLRY
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive

Pre-market earnings are flat-to-down at this hour, following another robust session Wednesday, led by an expanding AI trade and climbing gold values that have brought market indexes up double-digits from April lows. The Dow is -16 points, the S&P 500 +1 and the Nasdaq -4 points.

Read More
image for news Q3 Earnings Season Begins On Positive Note
Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
TLRY
Published: October 09, 2025 by: Benzinga
Sentiment: Positive

Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.

Read More
image for news Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
Tilray Brands stock surges as cannabis company posts Q1 profit
TLRY
Published: October 09, 2025 by: Proactive Investors
Sentiment: Positive

Tilray Inc (NASDAQ:TLRY) shares climbed 15% to US$1.98 in early trading on Thursday after the cannabis company announced that it swung to an adjusted net profit of $3.9 million for its fiscal first quarter 2025, from loss of $6.1 million during the same period last year. Its net revenue for the quarter rose 5% to $209.5 million, boosted by a 12% year over year increase in Canadian adult-use cannabis sales and 10% growth in international cannabis revenue.

Read More
image for news Tilray Brands stock surges as cannabis company posts Q1 profit
Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1
TLRY
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Neutral

Tilray Brands, Inc. (TLRY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.

Read More
image for news Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1
TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus
TLRY
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive

Tilray Brands' fiscal first-quarter report is likely to highlight international cannabis gains, European expansion and wellness growth.

Read More
image for news TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
CGC, TLRY, VFF
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive

Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.

Read More
image for news Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
Tilray stock price forecast as it faces major headwinds
TLRY
Published: September 30, 2025 by: Invezz
Sentiment: Negative

Tilray stock price has surged in the past few weeks, with most of the gains happening on Monday when it surged by over 60%, which brought its market capitalization to over $2 billion. It has now soared by over 440% from its lowest level this year.

Read More
image for news Tilray stock price forecast as it faces major headwinds
Best Canadian Cannabis Stocks to Watch for Growth and Opportunity
CGC, TLRY, VFF
Published: September 30, 2025 by: MarijuanaStocks
Sentiment: Positive

The U.S. cannabis industry has expanded rapidly, now generating over $33 billion in annual sales. Analysts project the market could exceed $56 billion by 2030. These figures highlight the growing opportunities for Canadian cannabis companies to target U.S. partnerships and eventual federal legalization. Recently, U.S. lawmakers renewed discussions about rescheduling cannabis under federal law. This sparked optimism and short-term volatility across cannabis stocks. Canadian firms remain positioned to benefit from regulatory progress and expanding cross-border demand. Their strategies include scaling production, diversifying product lines, and investing in branded distribution. As the industry evolves rapidly, investors must closely monitor these developments.

Read More
image for news Best Canadian Cannabis Stocks to Watch for Growth and Opportunity
Wall Street Breakfast Podcast: Weed Stocks Light Up
ACB, CGC, CRON, CURLF, GOOG, GOOGL, MCD, MSOS, TLRY
Published: September 30, 2025 by: Seeking Alpha
Sentiment: Positive

Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.

Read More
image for news Wall Street Breakfast Podcast: Weed Stocks Light Up
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
TLRY
Published: September 30, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray's EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray's ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical …

Read More
image for news Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
Markets Keep at All-Time Highs - Lots of Data Expected This Week
BP, KBH, LEN, NKE, PHM, TLRY, XOM
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive

Pending Homes Sales were better than expected, and cannabis stocks got a boost. But there is a lot of grist for the mill coming out in the coming days.

Read More
image for news Markets Keep at All-Time Highs - Lots of Data Expected This Week
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
ACB, CGC, CRON, TLRY
Published: September 29, 2025 by: New York Post
Sentiment: Positive

Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.

Read More
image for news Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Tilray Brands: What's Next For TLRY Stock?
TLRY
Published: September 24, 2025 by: Forbes
Sentiment: Positive

Tilray Brands (NASDAQ: TLRY) has witnessed a considerable surge, rising nearly 200% from $0.42 in early July to its present price of $1.24. This increase is largely attributed to the Trump administration's deliberation on reclassifying cannabis from a Schedule I to a Schedule III substance.

Read More
image for news Tilray Brands: What's Next For TLRY Stock?
Tilray stock price sits and waits for Trump cannabis rescheduling
TLRY
Published: September 17, 2025 by: Invezz
Sentiment: Neutral

The Tilray Brands stock price has staged a strong bullish rebound in the past few months, moving from a low of $0.352 in June to $1.25, up by 256%. Here's what to expect as market participants wait for the cannabis rescheduling.

Read More
image for news Tilray stock price sits and waits for Trump cannabis rescheduling
Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release
TLRY
Published: September 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

NANAIMO, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer-packaged goods company, announced that its premium craft cannabis brand Broken Coast is launching BC Selects, a new limited-edition line of premium cannabis flower that features unique phenotypes from its proprietary genetic library. The first strain in this series, Sprits 26, is now available exclusively in British Columbia, underscoring Broken Coast's dedication to precision and excellence in craft cannabis production.

Read More
image for news Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release
3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025
CGC, CRON, TLRY
Published: September 03, 2025 by: MarijuanaStocks
Sentiment: Positive

The cannabis industry continues to demonstrate why it deserves the same opportunities as other legitimate businesses. From an investment side, there are many who have put up big money in various global regions to be a part of this booming industry. Places like Canada and the USA are where the main markets exist. Now there are several parts to this, both bitter and sweet. Here is why it could be a bit bitter is with the potential of cannabis being rescheduled, it will give a major leg up to corporate cannabis versus small batch mom and pop cultivators.

Read More
image for news 3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025
Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
ACB, CGC, TLRY
Published: August 29, 2025 by: 24/7 Wall Street
Sentiment: Neutral

Key Points in This Article: Cannabis stocks surged in 2018-2019 on federal legalization hopes but crashed as progress stalled.

Read More
image for news Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
Tilray Brands shares gain as analysts boost price target on cannabis rescheduling optimism
TLRY
Published: August 26, 2025 by: Proactive Investors
Sentiment: Positive

Tilray Brands (NASDAQ:TLRY) shares continued to gain momentum on Tuesday after the cannabis firm saw its price target boosted by Jefferies analysts. The analysts, who maintained a ‘Buy' rating on Tilray, upped their price target to $2 from $1.50, citing growing optimism about a potential shift in US federal cannabis policy.

Read More
image for news Tilray Brands shares gain as analysts boost price target on cannabis rescheduling optimism
Top Canadian Marijuana Stocks to Watch in 2025 : Industry Growth and Legalization Updates
CGC, TLRY, VFF
Published: August 26, 2025 by: MarijuanaStocks
Sentiment: Positive

Investors are closely watching Canadian cannabis stocks this week amid rising U.S. industry momentum. The U.S. cannabis market hit an estimated $38.5 billion in 2024 and may grow at a compound annual growth rate (CAGR) of about 11–12 percent through the late 2020s. Meanwhile, several states are advancing reform. Notably, Delaware began adult-use cannabis sales on August 1, 2025. Moreover, at the federal level, the Trump administration signaled plans to reschedule marijuana from Schedule I to Schedule III, possibly within weeks. This could ease restrictions and boost stock sentiment. Altogether, these developments underline strong thematic tailwinds. Thus, Canadian cannabis stocks …

Read More
image for news Top Canadian Marijuana Stocks to Watch in 2025 : Industry Growth and Legalization Updates
Tilray Brands: Path To 5x Growth For TLRY Stock
TLRY
Published: August 26, 2025 by: Forbes
Sentiment: Positive

Tilray Brands (NASDAQ: TLRY) stock has already climbed 2x in the past month after reports that the Trump administration may reclassify marijuana, underscoring the market's recognition of this transformative catalyst. But how significant could this opportunity become for Tilray?

Read More
image for news Tilray Brands: Path To 5x Growth For TLRY Stock
Tilray's High Hopes: The Catalyst Driving Cannabis Stocks
TLRY
Published: August 21, 2025 by: MarketBeat
Sentiment: Positive

A fairly consistent climb in Tilray Brands' NASDAQ: TLRY stock price has started to capture the market's attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, climbing over 133% in the last three months on massive trading volume.

Read More
image for news Tilray's High Hopes: The Catalyst Driving Cannabis Stocks
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
TLRY
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Neutral

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.03, denoting a -12.71% move from the preceding trading day.

Read More
image for news Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
TLRY
Published: August 14, 2025 by: Seeking Alpha
Sentiment: Positive

Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative

Read More
image for news Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Cannabis stocks surge as Trump consider reclassifying the drug
ACB, CGC, CRON, CURLF, NEVIF, TCNNF, TLRY
Published: August 11, 2025 by: Proactive Investors
Sentiment: Positive

Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a Schedule I drug, along with heroin and cocaine, to Schedule III.

Read More
image for news Cannabis stocks surge as Trump consider reclassifying the drug
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
CGC, CRON, TLRY
Published: August 11, 2025 by: CNBC
Sentiment: Positive

Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the industry, one investing chief said.

Read More
image for news Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification

About Tilray Brands, Inc. (TLRY)

  • IPO Date 2018-07-19
  • Website https://www.tilray.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Irwin David Simon
  • Employees 2650

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.